These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34015864)

  • 1. Criterion validity and discriminatory ability of the central sensitization inventory short form in individuals with inflammatory bowel diseases.
    Falling C; Stebbings S; Baxter GD; Gearry RB; Mani R
    Scand J Pain; 2021 Jul; 21(3):577-585. PubMed ID: 34015864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central Sensitization Inventory Mediates the Relationship Between Inflammatory Bowel Disease Activity and Worse Musculoskeletal Pain Experiences.
    Falling CL; Stebbings S; Baxter DG; Gearry RB; Mani R
    Pain Pract; 2020 Jan; 20(1):24-33. PubMed ID: 31319013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptoms of central sensitization in patients with inflammatory bowel diseases: a case-control study examining the role of musculoskeletal pain and psychological factors.
    Falling C; Stebbings S; Baxter GD; Siegel CA; Gearry RB; Nijs J; Mani R
    Scand J Pain; 2021 Apr; 21(2):283-295. PubMed ID: 34387957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Musculoskeletal Pain in Individuals With Inflammatory Bowel Disease Reflects Three Distinct Profiles.
    Falling C; Stebbings S; Baxter GD; Gearry RB; Mani R
    Clin J Pain; 2019 Jul; 35(7):559-568. PubMed ID: 30829736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central sensitization and severity of gastrointestinal symptoms in irritable bowel syndrome, chronic pain syndromes, and inflammatory bowel disease.
    Midenfjord I; Grinsvall C; Koj P; Carnerup I; Törnblom H; Simrén M
    Neurogastroenterol Motil; 2021 Dec; 33(12):e14156. PubMed ID: 33860970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translation, cross-cultural adaptation, and measurement properties of the Nepali version of the central sensitization inventory (CSI).
    Sharma S; Jha J; Pathak A; Neblett R
    BMC Neurol; 2020 Jul; 20(1):286. PubMed ID: 32718330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the Japanese version of the Central Sensitization Inventory in patients with musculoskeletal disorders.
    Tanaka K; Nishigami T; Mibu A; Manfuku M; Yono S; Shinohara Y; Tanabe A; Ono R
    PLoS One; 2017; 12(12):e0188719. PubMed ID: 29216211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Convergent validity of the central sensitization inventory and experimental testing of pain sensitivity".
    Holm LA; Nim CG; Lauridsen HH; Filtenborg JB; O'Neill SF
    Scand J Pain; 2022 Jul; 22(3):597-613. PubMed ID: 34668367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative Sensory Testing Discriminates Central Sensitization Inventory Scores in Participants with Chronic Musculoskeletal Pain: An Exploratory Study.
    Zafereo J; Wang-Price S; Kandil E
    Pain Pract; 2021 Jun; 21(5):547-556. PubMed ID: 33342049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity of the central sensitization inventory with measures of sensitization in people with knee osteoarthritis.
    Gervais-Hupé J; Pollice J; Sadi J; Carlesso LC
    Clin Rheumatol; 2018 Nov; 37(11):3125-3132. PubMed ID: 30178171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central Sensitization Inventory is a useless instrument for detection of the impairment of the conditioned pain modulation in patients with chronic musculoskeletal pain.
    Cliton Bezerra M; Valentim Bittencourt J; Reis FJJ; de Almeida RS; Meziat-Filho NAM; Nogueira LAC
    Joint Bone Spine; 2021 May; 88(3):105127. PubMed ID: 33359767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and psychometric properties of short form of central sensitization inventory in participants with musculoskeletal pain: A cross-sectional study.
    Nishigami T; Tanaka K; Mibu A; Manfuku M; Yono S; Tanabe A
    PLoS One; 2018; 13(7):e0200152. PubMed ID: 29975754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishing Clinically Relevant Severity Levels for the Central Sensitization Inventory.
    Neblett R; Hartzell MM; Mayer TG; Cohen H; Gatchel RJ
    Pain Pract; 2017 Feb; 17(2):166-175. PubMed ID: 26989894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The central sensitization inventory predict pain-related disability for musculoskeletal disorders in the primary care setting.
    Tanaka K; Murata S; Nishigami T; Mibu A; Manfuku M; Shinohara Y; Tanabe A; Ono R
    Eur J Pain; 2019 Oct; 23(9):1640-1648. PubMed ID: 31233655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does a combination of self-reported signs related to central sensitization and pressure pain threshold allow for a more detailed classification of pain-related characteristics in patients with chronic musculoskeletal pain?: A cross-sectional study.
    Mibu A; Nishigami T; Tanaka K; Yono S; Manfuku M; Imai R
    Pain Pract; 2022 Jul; 22(6):556-563. PubMed ID: 35532035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutoff Value for Short Form of Central Sensitization Inventory.
    Tanaka K; Nishigami T; Mibu A; Manfuku M; Yono S; Yukioka M; Miki K
    Pain Pract; 2020 Mar; 20(3):269-276. PubMed ID: 31638741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing Validity of the Original and Rasch Versions of the Central Sensitization Inventory with Psychophysical Tests in People with Knee Osteoarthritis.
    Roby NU; Packham T; MacDermid JC; Carlesso LC
    Pain Med; 2023 Jun; 24(6):602-609. PubMed ID: 36472071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-Cultural Adaptation and Psychometric Properties of the European Portuguese Version of the Central Sensitization Inventory in Adolescents With Musculoskeletal Chronic Pain.
    Andias R; Silva AG
    Pain Pract; 2020 Jun; 20(5):480-490. PubMed ID: 32022985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Central Sensitization Inventory Score in elderly adults with musculoskeletal examination.
    Ide K; Yasuda T; Hasegawa T; Yamato Y; Yoshida G; Banno T; Arima H; Oe S; Mihara Y; Ushirozako H; Yamada T; Watanabe Y; Nakai K; Hoshino H; Matsuyama Y
    Mod Rheumatol; 2021 Jul; 31(4):885-889. PubMed ID: 32917120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the Central Sensitization Inventory (CSI) as a treatment outcome measure for patients with chronic spinal pain disorder in a functional restoration program.
    Neblett R; Hartzell MM; Williams M; Bevers KR; Mayer TG; Gatchel RJ
    Spine J; 2017 Dec; 17(12):1819-1829. PubMed ID: 28619687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.